Bo Gao

1986–2026 年に発表

920
論文数
56,190
被引用数
114
h 指数
546
i10 指数

被引用数

Bo Gao の年別被引用数1975 年: 被引用 1 件1977 年: 被引用 1 件1987 年: 被引用 4 件1988 年: 被引用 10 件1989 年: 被引用 9 件1990 年: 被引用 8 件1991 年: 被引用 9 件1992 年: 被引用 24 件1993 年: 被引用 18 件1994 年: 被引用 17 件1995 年: 被引用 12 件1996 年: 被引用 12 件1997 年: 被引用 10 件1998 年: 被引用 6 件1999 年: 被引用 11 件2000 年: 被引用 31 件2001 年: 被引用 64 件2002 年: 被引用 111 件2003 年: 被引用 124 件2004 年: 被引用 105 件2005 年: 被引用 118 件2006 年: 被引用 67 件2007 年: 被引用 80 件2008 年: 被引用 77 件2009 年: 被引用 133 件2010 年: 被引用 157 件2011 年: 被引用 211 件2012 年: 被引用 287 件2013 年: 被引用 310 件2014 年: 被引用 427 件2015 年: 被引用 371 件2016 年: 被引用 332 件2017 年: 被引用 439 件2018 年: 被引用 489 件2019 年: 被引用 1,203 件2020 年: 被引用 1,792 件2021 年: 被引用 2,226 件2022 年: 被引用 2,213 件2023 年: 被引用 1,858 件2024 年: 被引用 2,930 件2025 年: 被引用 1,885 件2026 年: 被引用 173 件2027 年: 被引用 1 件1976 年は被引用が無いため表示していません1978〜1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 6,692 件、この内訳の 25.9%アメリカ合衆国: 引用元論文 4,804 件、この内訳の 18.6%イギリス: 引用元論文 1,168 件、この内訳の 4.5%ドイツ: 引用元論文 1,005 件、この内訳の 3.9%イタリア: 引用元論文 870 件、この内訳の 3.4%日本: 引用元論文 837 件、この内訳の 3.2%カナダ: 引用元論文 760 件、この内訳の 2.9%フランス: 引用元論文 737 件、この内訳の 2.9%インド: 引用元論文 673 件、この内訳の 2.6%オーストラリア: 引用元論文 669 件、この内訳の 2.6%スペイン: 引用元論文 613 件、この内訳の 2.4%韓国: 引用元論文 526 件、この内訳の 2%
0%25.9%その他 25.1%

分野

  • Medicine38.5%
  • Biochemistry, Genetics and Molecular Biology18.7%
  • Computer Science12.2%
  • Engineering10.8%
  • Environmental Science3.4%
  • Neuroscience3.4%
  • その他13%

トピック

  • Cancer Immunotherapy and Biomarkers3.9%
  • Lung Cancer Treatments and Mutations1.1%
  • Head and Neck Cancer Studies1%
  • Lung Cancer Research Studies1%
  • Immunotherapy and Immune Responses0.9%
  • MicroRNA in disease regulation0.8%
  • その他91.3%

共著者

全論文

検索で開く
  1. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bo Gao, Brett Hughes, Girish Mallesara, Danny Rischin, Anne L. Taylor, Martin Burian, Thorsten Fuereder, Richard Greil, Carlos H. Barrios, Dalvaro Oliveira de Castro Junior, Gilberto de Castro, Fábio Franke, Gustavo Girotto, Iane Pinto Figueiredo Lima, Ulisses Ribaldo Nicolau, Gustavo Dix Junqueira Pinto, Lucas Vieira dos Santos, Ana-Paula Victorino, Neil Chua, Félix Couture, Richard Gregg, Aaron R. Hansen, John Hilton, Joy McCarthy, Denis Soulières, Rodrigo Ascuí, Pablo Gonzalez, Luis J. Villanueva-Rivera, Marco Torregroza, Ángela R. Zambrano, Petra Holečková, Zdeněk Král, Bohuslav Melichar, Prausova Jana, Milan Vošmik, Maria Andersen, Niels Gyldenkerne, Hannes Jürgens, Kadri Putnik, Petri Reinikainen, Viktor Gruenwald, Simon Laban, Gerasimos Aravantinos, Ioannis Boukovinas, Vassilis Georgoulias, Amanda Psyrri, D.L.W. Kwong, Yousuf Al-Farhat, Tibor Csőszi, József Erfán, Geza Horvai, László Landherr, Éva Remenár, Ágnes Ruzsa, Judit Szota, Salem Billan, Iris Gluck, Orit Gutfeld, Aron Popovtzer, Marco Benasso, Simona Bui, Vittorio Ferrari, Lisa Licitra, Franco Nolè, Takashi Fujii, Yasushi Fujimoto, Nobuhiro Hanai, Hiroki Hara, Koji Matsumoto, Kenji Mitsugi ほか 119 名 - The Lancet 2019 被引用: 3,211

  2. Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 2,963

  3. Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 被引用: 799

  4. PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Víctor Moreno, Jiaxin Niu, Taofeek K. Owonikoko, Kyriakos P. Papadopoulos, George D. Yancopoulos, Israel Lowy, Matthew G. Fury - New England Journal of Medicine 2018 被引用: 1,393

  5. Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sophia Frentzas, Ganessan Kichendasse, Bo Gao, Tarek Meniawy, Linda Mileshkin, Gary Richardson, Felicia Roncolato, Jean‐François Baurain, Maryam Bourhaba, Eveline Cuypere, Philip R. Debruyne, Hannelore Denys, Frédéric Forget, Brigitte Honhon, E. Joosens, Els Van Nieuwenhuysen, Vanessa da Costa Miranda, Andréia Cristina de Melo, Joao Daniel Guedes, Charles Andreé Joseph de Pádua, Nicolas Lazaretti, Carolina Martins Vieira, André Mattar, Daniela Neves Palmeiro, Christina Pimentel Oppermann Kussler, Pedro Emanuel Rubini Liedke, João Soares Nunes, Katsuki Arima Tiscoski, Allan Covens, Lara De Guerké, Prafull Ghatage, Lucy Gilbert, Susie Lau, Amit M. Oza, Diane Provencher, Omar Touhami, Congzhu Li, Danbo Wang, Ge Lou, Zhu Genhai, Guiling Li, Shi Hong, Hong Zheng, Wen Hongwu, Jihong Liu, Jing Wang, Ke Wang, Jiang Kui, Li Li, Wang Li, Hao Min, Qi Zhou, Gao Qinglei, Sihai Liao, Zhang Songling, Zhao Weidong, Xiaohua Wu, Wuliang Wang, Rutie Yin, Cheng Ying, Yu Zhang, Liang Zhiqing, Fernando Contreras Mejía, Ángel Luis Martín de Francisco Hernández, Carolina Ortiz Lopez, Carlos Javier Pacheco, Pedro Luis Ramos Guette, Jaime Rendon Pereira, Julian Rivera Diaz, Tomás Sánchez Villegas ほか 156 名 - Journal of Clinical Oncology 2023 被引用: 331

  6. Piezo1/2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP1-ß-catenin

    著者: , , , , , , , , , , , , , , , - eLife 2020 被引用: 359

  7. QTune: A Query-Aware Database Tuning System with Deep Reinforcement Learning

    著者: , , , - VLDB Endowment, Proc. VLDB Endow. 2019 被引用: 235

  8. Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2018 被引用: 451

  9. Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 被引用: 301

  10. Driving Style Recognition for Intelligent Vehicle Control and Advanced Driver Assistance: A Survey

    著者: , , , , - IEEE Transactions on Intelligent Transportation Systems, IEEE Trans. Intell. Transp. Syst. 2017 被引用: 611

  11. Bone mesenchymal stem cells stimulation by magnetic nanoparticles and a static magnetic field: release of exosomal miR-1260a improves osteogenesis and angiogenesis

    著者: , , , , , , , , , , , - Journal of Nanobiotechnology 2021 被引用: 258

  12. A gut microbial signature for combination immune checkpoint blockade across cancer types

    著者: , , , , , , , , , , , , , , , , , - Nature Medicine 2024 被引用: 127

  13. Sum-Rate Maximization in STAR-RIS-Assisted RSMA Networks: A PPO-Based Algorithm

    著者: , , , , , - IEEE Internet of Things Journal, IEEE Internet Things J. 2023 被引用: 72

  14. Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 被引用: 306

  15. Apoptotic bodies derived from mesenchymal stem cells promote cutaneous wound healing via regulating the functions of macrophages

    著者: , , , , , , , , , , , , , , , - Stem Cell Research & Therapy 2020 被引用: 178

  16. Exosomes Derived from Bone Mesenchymal Stem Cells with the Stimulation of Fe3O4 Nanoparticles and Static Magnetic Field Enhance Wound Healing Through Upregulated miR-21-5p

    著者: , , , , , , , , , , , - International Journal of Nanomedicine 2020 被引用: 201

  17. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margaret McGrath, Richard Greil, Dietmar Thurnher, Thorsten Fuereder, Martin Burian, Sylvie Rottey, Jean‐Pascal Machiels, Paul Clement, Stéphanie Henry, S. Deheneffe, Gustavo Vasconcelos Alves, Iane Pinto Figueiredo Lima, Josiane Mourão Dias, Pedro Rafael Martins De Marchi, Milena Perez Mak, Andrea Juliana Gomes, Dalvaro Oliveira de Castro Junior, Tatiane Cardoso Motta, Mônica Luciana Agostinho Padoan, Ana Paula Victorina, Sérgio Jobim Azevedo, Lillian L. Siu, Stephanie Yasmin Brule, John Hilton, Chang Shu Wang, Nathaniel Bouganim, Marc Webster, John Walker, Neil Chua, Ángela R. Zambrano, Alicia Quiroga Echeverri, Oscar Mauricio Niño Gomez, Carlos Alberto Ortiz, Luis Alejandro Rojas, Andrés Cardona Zorilla, Olga Marcela Urrego Meléndez, Petra Holečková, Bohuslav Melichar, Jakub Cvek, Jana Prausová, Milan Vošmik, Jean‐Pierre Delord, Xavier Zasadny, Lionnel Geoffrois, Yungan Tao, Y. Pointreau, Rainer Fietkau, Marlen Haderlein, Andreas Müller, Ursula C. Schroeder, Barbara Wollenberg, Simon Laban, Philipp Ivanyi, Viktor Gruenwald, Philippe Schafhausen, Orit Gutfeld, Iris Gluck, Aron Popovtzer, Amichay Meirovitz, Salem Billan, Baruch Brenner, Aron Popovtzer, Dror Limon, Lisa Licitra, Francesco Perri, Francesco Caponigro, Martina Violati, Daris Ferrari, Franco Nolè, Federica Bertolini ほか 90 名 - The Lancet Oncology 2024 被引用: 210

  18. Joint Coordinated Beamforming and Power Splitting Ratio Optimization in MU-MISO SWIPT-Enabled HetNets: A Multi-Agent DDQN-Based Approach

    著者: , , , , , - IEEE Journal on Selected Areas in Communications, IEEE J. Sel. Areas Commun. 2021 被引用: 95

  19. An Overview of Dynamic Spectrum Sharing: Ongoing Initiatives, Challenges, and a Roadmap for Future Research

    著者: , , , , - IEEE Transactions on Cognitive Communications and Networking, IEEE Trans. Cogn. Commun. Netw. 2016 被引用: 271

  20. NLRP1 inflammasome contributes to chronic stress-induced depressive-like behaviors in mice

    著者: , , , , , , , - Journal of Neuroinflammation 2020 被引用: 203

  21. Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2019 被引用: 438

  22. Deep Convolutional Neural Network-Based Epileptic Electroencephalogram (EEG) Signal Classification

    著者: , , , , - Frontiers in Neurology 2020 被引用: 214

  23. Beam Management in Millimeter-Wave Communications for 5G and Beyond

    著者: , , , - IEEE Access 2020 被引用: 175

  24. Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Brungs, Bo Gao, Adnan Nagria, Christos S. Karapetis, Sagun Parakh, Cheol Park, Gaëtan Catala, Frédéric Forget, Sebahat Ocak, Naveen S. Basappa, Geoffrey Liu, Ines B. Menjak, Benjamin Shieh, Shun Lü, Feng Luo, Hongmei Sun, Jialei Wang, Yu Yao, Milada Zemanová, Jaafar Bennouna, Nicolas Girard, Laurent Greillier, Corinne Lamour, H. Léna, Céline Mascaux, Julien Mazières, Denis Moro‐Sibilot, M. Pérol, Elvire Pons‐Tostivint, Virginie Westeel, Akin Atmaca, Christine Greil, Niels Reinmuth, Christian Schumann, Thomas Wehler, Juergen Wolf, James Ho, Csaba Böcskei, Federico Cappuzzo, Filippo de Marinis, Claudia Proto, Manlio Mencoboni, Silvia Novello, Stefania Salvagni, Héctor Soto Parrà, Haruko Daga, Yasushi Goto, Hidetoshi Hayashi, Satoru Kitazono, Kiyotaka Yoh, Ryo Ko, Masashi Kondo, Toshiyuki Kozuki, Takayasu Kurata, Hideaki Mizutani, Kadoaki Ohashi, Satoshi Oizumi, Isamu Okamoto, Satoshi Sakaguchi, H Ozasa, Shunichi Sugawara, Yuichi Tambo, Motohiro Tamiya, Hiroshi Tanaka, Isamu Okamoto, Froylán López-López, Francisco Javier Ramírez Godinez, Jerónimo Rafael Rodríguez Cid, Robin Cornelissen, Steven Gans ほか 61 名 - Journal of Clinical Oncology 2024 被引用: 182